FindMyRecallSubscribe
Class I: serious health riskTerminated

Bristol-Meyers Squibb Coumadin For Injection Recall

COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only…

Bristol-Meyers Squibb · Princeton, NJ

Risk level
Class I
Reported by FDA
Sep 24, 2014
Recall ID
D-1595-2014
Check your lot numberHow we source this data

Summary

Bristol-Meyers Squibb recalled Coumadin For Injection starting May 12, 2014. The FDA classified it as Class I (serious health risk) and published enforcement report D-1595-2014 on Sep 24, 2014. Reason: Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials

Product description

COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96

Lot numbers, UPCs & expiration codes

Lot 00201125, Exp. 09/14; 00201126 Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp. 07/15; 00201230, Exp. 09/15

Where it was sold

Nationwide, Canada

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1595-2014
Classification
Class I
Status
Terminated
Recall initiated
May 12, 2014
FDA report date
Sep 24, 2014
Quantity
50,724 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Bristol-Meyers Squibb

Original FDA data

Every field from FDA enforcement report D-1595-2014, exactly as published.

Show all FDA fields
City
Princeton
State
NJ
Status
Terminated
Country
United States
Event ID
68276
Address
PO Box 4000
Code information
Lot 00201125, Exp. 09/14; 00201126 Exp.11/14; 00201127, Exp.12/14; 00201228 Exp.06/15; 00201229 Exp. 07/15; 00201230, Exp. 09/15
Postal code
08543-4000
Report date
Sep 24, 2014
Product type
Drugs
Recall number
D-1595-2014
Classification
Class I
Recalling firm
Bristol-Meyers Squibb
Product quantity
50,724 Vials
Termination date
May 29, 2015
Reason for recall
Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials
Voluntary / mandated
Voluntary: Firm initiated
Product description
COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96
Distribution pattern
Nationwide, Canada
Recall initiation date
May 12, 2014
Initial firm notification
Letter
Center classification date
Sep 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1595-2014, published Sep 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls